181 related articles for article (PubMed ID: 2985398)
1. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
3. Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies.
Carrel S; de Tribolet N; Mach JP
Acta Neuropathol; 1982; 57(2-3):158-64. PubMed ID: 6181646
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
[TBL] [Abstract][Full Text] [Related]
5. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
[TBL] [Abstract][Full Text] [Related]
6. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
7. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
8. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
11. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human tumor cells for Ia-like antigens with monoclonal antibodies.
Howe AJ; Seeger RC; Molinaro GA; Ferrone S
J Natl Cancer Inst; 1981 May; 66(5):827-9. PubMed ID: 6262557
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic dynamics of tumor progression in human malignant melanoma.
Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
[TBL] [Abstract][Full Text] [Related]
14. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
15. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
16. Five novel cell surface antigens of CNS neoplasms.
Jennings MT; Jennings VD; Asadourian LL; Rosenblum M; Albino AP; Cairncross JG; Old LJ
J Neurol Sci; 1989 Jan; 89(1):63-78. PubMed ID: 2926443
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.
Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
Br J Cancer; 1993 Nov; 68(5):831-7. PubMed ID: 8217597
[TBL] [Abstract][Full Text] [Related]
18. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes.
Holzmann B; Bröcker EB; Lehmann JM; Ruiter DJ; Sorg C; Riethmüller G; Johnson JP
Int J Cancer; 1987 Apr; 39(4):466-71. PubMed ID: 3104215
[TBL] [Abstract][Full Text] [Related]
20. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
